Hapvida Participações e Investimentos S.A. Share Price

Equities

HAPV3

BRHAPVACNOR4

Managed Healthcare

Market Closed - Sao Paulo 01:41:40 18/05/2024 am IST 5-day change 1st Jan Change
4.51 BRL +23.90% Intraday chart for Hapvida Participações e Investimentos S.A. +11.36% +1.35%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2.9TCr 568.18Cr 47TCr Sales 2025 * 3.17TCr 620.86Cr 52TCr Capitalization 3.38TCr 662.35Cr 55TCr
Net income 2024 * 27Cr 5.29Cr 440.66Cr Net income 2025 * 125.5Cr 25Cr 2.05TCr EV / Sales 2024 * 1.31 x
Net Debt 2024 * 406.35Cr 80Cr 6.63TCr Net Debt 2025 * 95Cr 19Cr 1.55TCr EV / Sales 2025 * 1.1 x
P/E ratio 2024 *
106 x
P/E ratio 2025 *
32.6 x
Employees 66,000
Yield 2024 *
0.11%
Yield 2025 *
0.92%
Free-Float 63.39%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Hapvida Participações e Investimentos S.A., Q1 2024 Earnings Call, May 14, 2024
Hapvida Participações e Investimentos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Hapvida Participações e Investimentos S.A., Q4 2023 Earnings Call, Apr 01, 2024
Hapvida Participações E Investimentos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Hapvida Participações e Investimentos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Hapvida Participações e Investimentos S.A.(BOVESPA:HAPV3) dropped from Brazil Valor BM&FBOVESPA Index CI
Brazil's Hapvida CFO resigns, moves to board seat RE
Transcript : Hapvida Participações e Investimentos S.A., Q3 2023 Earnings Call, Nov 09, 2023
Hapvida Participações e Investimentos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Hapvida Shares Rise 3.4% After Positive Analyst Report DJ
News Highlights : Top Financial Services News of the Day DJ
Transcript : Hapvida Participações e Investimentos S.A., Q2 2023 Earnings Call, Aug 10, 2023
Hapvida Participações e Investimentos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Brazil's Hapvida posts 8% drop in Q2 adjusted net profit RE
Hapvida Shares Rise 5.3% After Making Changes to Board DJ
More news

Latest transcript on Hapvida Participações e Investimentos S.A.

1 day+23.90%
1 week+11.36%
Current month+22.22%
1 month+25.28%
3 months+29.23%
6 months-1.53%
Current year+1.35%
More quotes
1 week
4.26
Extreme 4.26
4.59
1 month
3.49
Extreme 3.49
4.59
Current year
3.31
Extreme 3.31
4.63
1 year
3.31
Extreme 3.31
5.42
3 years
1.93
Extreme 1.93
16.25
5 years
1.93
Extreme 1.93
18.48
10 years
1.93
Extreme 1.93
18.48
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 -
Chief Operating Officer - 14/21/14
Director/Board Member 53 01/01/01
Members of the board TitleAgeSince
Director/Board Member 54 -
Director/Board Member 70 -
Director/Board Member 61 01/18/01
More insiders
Date Price Change Volume
17/24/17 4.51 +0.45% 82,320,900
16/24/16 4.49 +2.05% 67,044,300
15/24/15 4.4 -1.12% 59,540,100
14/24/14 4.45 +10.42% 222,798,300
13/24/13 4.03 -0.49% 60,063,200

Delayed Quote Sao Paulo, May 18, 2024 at 01:41 am IST

More quotes
Hapvida Participações e Investimentos S.A. is specialized in providing health and dental care services to individuals and businesses covered by the group's health and dental care insurance plans. In addition, the group provides healthcare services to uninsured patients. The business activity is structured around 2 areas: - sale of health insurance plans (#1 in Brazil): 4.3 million customers as of the end of 2021; - sale of dental insurance plans (#3 in Brazil): 3.3 million customers. As of the end of 2021, the group's business activity has been conducted through a network of 481 healthcare institutions, including 49 hospitals (3,028 beds), 49 emergency care units, 205 clinics, and 178 diagnostic imaging laboratories and centers located in Brazil.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
4.51 BRL
Average target price
5.756 BRL
Spread / Average Target
+27.62%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW